Company news
Shattuck Labs, Inc. (NASDAQ:STTK) news
Shattuck Labs, Inc. news releases on 6ix. Latest, Aug 10, 2023: Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Press releases — page 2
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 9, 2023
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 8, 2023
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference
April 2, 2023
Shattuck Labs Announces Participation in Upcoming March Conferences
February 28, 2023
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
February 22, 2023
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
January 8, 2023
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 6, 2022
Shattuck Labs Announces Participation in Upcoming November Conferences
November 2, 2022
Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022
October 31, 2022
Shattuck Labs Announces Participation in Upcoming September Conferences
August 31, 2022
Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights
August 10, 2022
Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 11, 2022
Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference
April 4, 2022
Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference
February 8, 2022
Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252
November 8, 2021
Shattuck Labs to Host Conference Call and Webcast Highlighting Data Presented at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 3, 2021
Shattuck Labs Announces Changes to its Board of Directors
October 27, 2021
Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252
August 10, 2021
Shattuck Labs Announces Participation in the BTIG Biotechnology Conference
August 5, 2021
Shattuck Labs Appoints Abhinav A. Shukla as Chief Technical Officer
May 31, 2021
Shattuck Labs Announces Participation in Upcoming May Conferences
April 29, 2021
Shattuck Labs Announces Participation in Needham’s 20th Annual Healthcare Conference
April 5, 2021
Shattuck Labs Announces Promotion of Andrew R. Neill to Chief Financial Officer
March 15, 2021
Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
March 14, 2021
Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day
February 11, 2021
Shattuck Labs Added to Russell 2000® and 3000® Indexes
December 17, 2020
Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020
November 10, 2020
Shattuck Labs Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
October 13, 2020
Shattuck Labs Announces Pricing of Upsized Initial Public Offering
October 7, 2020